Skip to main navigation Skip to search Skip to main content

A Double- Blind, Randomized, Multicenter Study Followed by 6 Months Open- Label Treatment to Evaluate the Dose- Response and Safety of Valsartan in Pediatric Hyperintensive Patients

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date10/1/02 → 11/30/05

Funding

  • Novartis Pharmaceuticals Corporation: $2,056.96